Bristol-Myers Squibb Co. | Ownership
Companies that own Bristol-Myers Squibb Co.
Wellington Management Co. LLP
141,623,193
8.68%
1,966,533
1.61%
06/30/2018
The Vanguard Group, Inc.
124,697,001
7.64%
2,064,065
0.24%
06/30/2018
BlackRock Fund Advisors
74,654,779
4.58%
-77,437
0.23%
06/30/2018
SSgA Funds Management, Inc.
61,498,837
3.77%
-1,395,761
0.28%
06/30/2018
Dodge & Cox
32,705,086
2%
4,887,475
1.04%
06/30/2018
Capital Research & Management Co. (World Investors)
25,210,057
1.55%
-3,999,751
0.21%
06/30/2018
Northern Trust Investments, Inc.
22,155,107
1.36%
-740,132
0.3%
06/30/2018
Columbia Management Investment Advisers LLC
21,741,612
1.33%
7,097,620
0.76%
06/30/2018
Geode Capital Management LLC
20,175,314
1.24%
388,721
0.31%
06/30/2018
PRIMECAP Management Co.
18,043,794
1.11%
1,612,844
0.74%
06/30/2018
| Address |
430 East 29th Street
New York New York 10154
United States
|
|
Employees
|
- |
| Website |
http://www.bms.com |
| Updated |
07/08/2019 |
| Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY. |
